An initiative of Flandersbio

Listed companies

Listed companies

in english

The combined market cap of Belgian SME biotech companies gained top position in the European ranking. The fact that the number of qualifying companies is 2 to 3 times smaller than in other European countries confirms the intrinsic quality of the Belgian public biotech sector.

Celyad

Incorporated in 2007, Celyad is a Belgian biopharmaceutical company, leader in the discovery and development of engineered cell therapies with clinical programs in cardiovascular disease (C-Cure®) and immuno-oncology (NKR-T).

Celyad on FlandersBio.be

 

Chart IPO Statistics Pipeline Contact

Click on the chart to follow the daily exchange rate.

View the NYSE Euronext chart

  • Listing date:   05/07/2013

View chart De Tijd

Product Indications and progress Partner
C-Cure CHF
 
C3BS-GQR-1 AMI
 
C3BS-GQR-4 AMI
 
C3BS-PQR-1 Congenital Heart Defects
 
C-Cath Intramyocardial injection catheter
 

Investor Relations:
Patrick Jeanmart, CFO
Email:
Phone: +32 1 039 41 00

Address details:
Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium
Website: http://www.celyad.com
Email:

Back to top

Print